These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 27893290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cholangiocarcinoma.
    Krasinskas AM.
    Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
    [Abstract] [Full Text] [Related]

  • 5. Coming of a precision era of the staging systems for intrahepatic cholangiocarcinoma?
    Cheng Z, Lei Z, Shen F.
    Cancer Lett; 2019 Sep 28; 460():10-17. PubMed ID: 31212000
    [Abstract] [Full Text] [Related]

  • 6. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
    Brown ZJ, Hewitt DB, Pawlik TM.
    Front Biosci (Landmark Ed); 2022 Mar 05; 27(3):85. PubMed ID: 35345317
    [Abstract] [Full Text] [Related]

  • 7. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
    Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS.
    Cancer; 2016 May 01; 122(9):1349-69. PubMed ID: 26799932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
    Ross JS, Wang K, Gay L, Al-Rohil R, Rand JV, Jones DM, Lee HJ, Sheehan CE, Otto GA, Palmer G, Yelensky R, Lipson D, Morosini D, Hawryluk M, Catenacci DV, Miller VA, Churi C, Ali S, Stephens PJ.
    Oncologist; 2014 Mar 01; 19(3):235-42. PubMed ID: 24563076
    [Abstract] [Full Text] [Related]

  • 13. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
    Putra J, de Abreu FB, Peterson JD, Pipas JM, Mody K, Amos CI, Tsongalis GJ, Suriawinata AA.
    Exp Mol Pathol; 2015 Oct 01; 99(2):240-4. PubMed ID: 26189129
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.
    Stutes M, Tran S, DeMorrow S.
    World J Gastroenterol; 2007 Dec 28; 13(48):6465-9. PubMed ID: 18161915
    [Abstract] [Full Text] [Related]

  • 16. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
    Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY, Li SP.
    BMC Cancer; 2015 Feb 18; 15():64. PubMed ID: 25880914
    [Abstract] [Full Text] [Related]

  • 17. Current challenges to underpinning the genetic basis for cholangiocarcinoma.
    Cigliano A, Chen X, Calvisi DF.
    Expert Rev Gastroenterol Hepatol; 2021 May 18; 15(5):511-526. PubMed ID: 33888034
    [Abstract] [Full Text] [Related]

  • 18. Systemic treatment of advanced or recurrent biliary tract cancer.
    Zhang W, Zhou H, Wang Y, Zhang Z, Cao G, Song T, Zhang T, Li Q.
    Biosci Trends; 2020 Nov 04; 14(5):328-341. PubMed ID: 32830166
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.